ScinoPharm Taiwan, Ltd. (TPE:1789)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Inter Segment	-431.89M	-519.61M	-342.84M	-388.66M	-421.22M
Changshu Shenlong	679.16M	645.26M	494.83M	482.18M	440.66M
Changshu Shenlong Growth	5.25%	30.40%	2.62%	9.42%	5.20%
Others	19.95M	53.48M	42.62M	25.99M	17.27M
Others Growth	-62.69%	25.47%	64.00%	50.52%	-56.38%
Scinopharm Taiwan, Ltd.	3.14B	3.01B	3.07B	2.64B	3.05B
Scinopharm Taiwan, Ltd. Growth	4.39%	-2.04%	16.14%	-13.24%	8.29%
Total	3.41B	3.19B	3.26B	2.76B	3.08B
Total Growth	6.91%	-2.39%	18.16%	-10.40%	6.57%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Asia	1.42B	1.17B	1.09B	999.19M	761.57M
Asia Growth	20.62%	7.81%	8.93%	31.20%	-13.95%
Europe	675.06M	690.17M	582.66M	583.05M	1.19B
Europe Growth	-2.19%	18.45%	-0.07%	-51.11%	35.32%
India	529.29M	525.27M	577.19M	227.80M	358.42M
India Growth	0.77%	-9.00%	153.38%	-36.44%	-8.20%
United States	403.66M	490.58M	635.74M	766.06M	579.04M
United States Growth	-17.72%	-22.83%	-17.01%	32.30%	1.92%
Taiwan	346.88M	271.50M	261.87M	110.04M	129.01M
Taiwan Growth	27.76%	3.68%	137.98%	-14.71%	32.35%
Other	36.07M	35.20M	118.18M	76.19M	62.28M
Other Growth	2.47%	-70.21%	55.11%	22.35%	-11.49%
Total	3.41B	3.19B	3.26B	2.76B	3.08B
Total Growth	6.91%	-2.39%	18.16%	-10.40%	6.57%

Source: S&P Global Market Intelligence.